Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Molecular Remission by ASO-RQ-PCR Technique After Induction Treatment With Bortezomib-dexamethasone (Vel/Dex) Followed by HDT With ASCT

NCT00861250 is registered in ClinicalTrials.gov with Tampere University Hospital as lead sponsor.

NCT NCT00861250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00861250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Molecular Remission by ASO-RQ-PCR Technique After Induction Treatment With Bortezomib-dexamethasone (Vel/Dex) Followed by HDT With ASCT
Lead sponsor
Tampere University Hospital
Phase
Phase 2/3
Overall status
Completed
Start date
March 31, 2009
Completion date
July 31, 2015
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma